Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion-Positive Lung Cancer. Waliany S, Lin JJ. J Clin Oncol 2024 Jun 28:JCO2401062. doi: 10.1200/JCO.24.01062.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Waliany S, Lin JJ. Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion-Positive Lung Cancer. J Clin Oncol 2024 Jun 28:JCO2401062. doi: 10.1200/JCO.24.01062.
PMID: 38941567